Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

China $30+ Billion Cancer Drugs Market to 2025 by Drugs, Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy, Companies - ResearchAndMarkets.com

December 18, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Dec 18, 2019--

The “China Cancer Drugs Market, by Drugs, Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy, Companies” report has been added to ResearchAndMarkets.com’s offering.

China Cancer Drug Market will surpass US$ 30.5 Billion by the year end of 2025.

Cancer is one of the biggest burdens for so many public health departments across the world and China has even more cancer patients due to growing population at rapid pace. According to GLOBCAN, nearly 2.9 Million new cancer deaths happened in China in the year 2018.

If we talk about cancer incidence, this rate is much lower in China rather than United States and United Kingdom. But when we talk about mortality rate, China mortality rate is almost 30% to 40% higher than the United States and United Kingdom. Moreover, increasing diagnostic center, improving cancer treatment therapy and acceptance of targeted drug therapy will further boost the China cancer market in forecast period. However, expensive cancer drug and various side-effects will also hinder the market.

China cancer drug market has grown rapidly in historical period and it is expected to grow significantly during the forecast period. There are various factors that will help the market to outperform; rising ageing population in China, changes of lifestyle and food habits, rising incidence rate of several type of cancer, rise in tobacco smoking population due to expansion of urbanization in China, improving healthcare infrastructure and facilities in China, increasing per capita disposable income, rising per capita healthcare expenditure, improving awareness regarding cancer risk, potential due to emerging economies etc.

China Cancer Drug Market Insight by Drug Type

In this report, China cancer drugs market is fragmented by drug type into six parts; Targeted Drugs, Cytotoxic Drugs, Monoclonal Antibiotics, Hormonal Drugs, TCM and Others. Cytotoxic Drugs type is further categorized into three parts; Antimetabolites, Plant Alkaloids and Alkylating Agents. Currently targeted drugs have more ability to kill malignant cells and it is quite popular because of higher success rate and efficacy.

China Cancer Drug Market Insight by Types of Cancer

In this report, we have done in-depth analysis of market by types of cancer; Lung, Stomach, Breast, Esophageal, Liver & Others.

China Cancer Drug Market Insight by Therapy

According to the publisher, targeted drug therapy is growing significantly in China due its higher efficacy and success rate than other therapy. In this report, we have design multi-dimensional approach to study all the cancer therapy which includes various important variables such as prime factors that support market growth, opportunities in each therapy, challenges faced by particular therapy, etc.

Market Dynamics

Growth Drivers


By Drugs

By Cancer

By Therapy

Companies Covered in the Report

For more information about this report visit https://www.researchandmarkets.com/r/kk7fcs

View source version on businesswire.com:https://www.businesswire.com/news/home/20191218005477/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 12/18/2019 09:52 AM/DISC: 12/18/2019 09:52 AM